Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Lim

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Cancer Letters|March 6, 2012
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cellsJoshua Bliesath, Nanni Huser, Mayuko Omori, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Oncogene|August 24, 2011
Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblastsD Perna, G Fagà, A Verrecchia, et al.
Bio-Protocol|June 14, 2021
COVID-19 Sample Pooling: From RNA Extraction to Quantitative Real-time RT-PCRKenny Voon, Nur Alia Johari, Khai Lone Lim, et al.
Plos Pathogens|July 9, 2020
The endosymbiont Wolbachia rebounds following antibiotic treatmentEmma L Gunderson, Ian Vogel, Laura Chappell, et al.
Molecular Cancer Therapeutics|January 24, 2012
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapyAdam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, et al.
Plos Neglected Tropical Diseases|February 21, 2015
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasisChristina A Bulman, Chelsea M Bidlow, Sara Lustigman, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Cancer Letters|March 6, 2012
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cellsJoshua Bliesath, Nanni Huser, Mayuko Omori, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Oncogene|August 24, 2011
Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblastsD Perna, G Fagà, A Verrecchia, et al.
Bio-Protocol|June 14, 2021
COVID-19 Sample Pooling: From RNA Extraction to Quantitative Real-time RT-PCRKenny Voon, Nur Alia Johari, Khai Lone Lim, et al.
Plos Pathogens|July 9, 2020
The endosymbiont Wolbachia rebounds following antibiotic treatmentEmma L Gunderson, Ian Vogel, Laura Chappell, et al.
Molecular Cancer Therapeutics|January 24, 2012
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapyAdam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, et al.
Plos Neglected Tropical Diseases|February 21, 2015
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasisChristina A Bulman, Chelsea M Bidlow, Sara Lustigman, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.
Pageof 10